Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Neurovascular dysfunction substantially contributes to Alzheimer disease. Here, we show that transcriptional profiling of human brain endothelial cells (BECs) defines a subset of genes whose expression is age-independent but is considerably altered in Alzheimer disease, including the homeobox gene MEOX2 (also known as GAX), a regulator of vascular differentiation, whose expression is low in Alzheimer disease. By using viral-mediated MEOX2 gene silencing and transfer, we show that restoring expression of the protein it encodes, GAX, in BECs from individuals with Alzheimer disease stimulates angiogenesis, transcriptionally suppresses AFX1 forkhead transcription factor-mediated apoptosis and increases the levels of a major amyloid-beta peptide (Abeta) clearance receptor, the low-density lipoprotein receptor-related protein 1 (LRP), at the blood-brain barrier. In mice, deletion of Meox2 (also known as Gax) results in reductions in brain capillary density and resting cerebral blood flow, loss of the angiogenic response to hypoxia in the brain and an impaired Abeta efflux from brain caused by reduced LRP levels. The link of MEOX2 to neurovascular dysfunction in Alzheimer disease provides new mechanistic and therapeutic insights into this illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microvessels have thickened basement membranes, become tortuous, and are reduced in number.71,105–107”
In the citing paper
“In fact, there is an angiogenesis hypothesis for Alzheimer disease and a possible role for genes in neurovascular unit dysfunction in Alzheimer disease.107,492”
In the citing paper
“Despite a pronounced pro-angiogenic response, AD brains fail to mount an adequate angiogenic response to renew lost capillary networks likely due to the loss of the homeobox gene MEOX2 from endothelium (656), and ongoing pericyte degeneration (570).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [656]
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,276
Holland, P. M., Abramson, R. D., Watson, R., & Gelfand, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7276 · Cited by 2,693
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Baldi, P., & Long, A. D. (2001) · Bioinformatics · doi:10.1093/bioinformatics/17.6.509 · Cited by 1,618
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Uber eine eigenartige Erkrankung der Hirnrinde
Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Initiation of translation in prokaryotes and eukaryotes
Kozak, M. (1999) · Gene · doi:10.1016/s0378-1119(99)00210-3 · Cited by 1,364
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
“Low levels of MEOX-2 expression mediate abnormal angiogenic responses of AD BEC to VEGF and other angiogenic factors (Wu et al., 2005), resulting in premature vessel regression, reduced resting CBF, and improper formation of the BBB (Figure 5B).”
InfluentialBlennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076
Self-citationNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Phenotypic Heterogeneity of the Endothelium: I. Structure, Function, and Mechanisms
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255691.76142.4a · Cited by 1,750
Bell, R. D., Winkler, E. A., Sagare, A. P., Singh, I., LaRue, B., Deane, R., & Zlokovic, B. V. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.043 · Cited by 1,448
Self-citationPhenotypic Heterogeneity of the Endothelium: II. Representative Vascular Beds
Aird, W. C. (2007) · Circulation Research · doi:10.1161/01.res.0000255690.03436.ae · Cited by 1,257
Central nervous system pericytes in health and disease
Winkler, E. A., Bell, R. D., & Zlokovic, B. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2946 · Cited by 962
Self-citationNeurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Self-citationThe blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767
“Previous studies have shown that deletion of MEOX2 leads to reduction of brain capillary density and cerebral blood fl ow, loss of the angiogenic response to hypoxia in the brain and reduced LRP1 expression in a mouse model of AD (Wu et al., 2005).”
Timmons, J. A., Wennmalm, K., Larsson, O., Walden, T. B., Lassmann, T., Petrovic, N., Hamilton, D. L., Gimeno, R. E., Wahlestedt, C., Baar, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610615104 · Cited by 732
GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration
Winkler, E. A., Nishida, Y., Sagare, A. P., Rege, S. V., Bell, R. D., Perlmutter, D., Sengillo, J. D., Hillman, S., Kong, P., Nelson, A. R., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3966 · Cited by 689
Self-citationNeurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease
Nelson, A. R., Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.016 · Cited by 559
Self-citationThe overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Iadecola, C. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0718-6 · Cited by 557
“For example, the homeobox gene MEOX, critical for vascular differentiation, is suppressed in patients with AD and may mediate the cerebral microvascular rarefaction observed in this disease [125].”
Deane, R., Bell, R., Sagare, A., & Zlokovic, B. (2009) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152709787601867 · Cited by 548
Self-citationCerebral Perfusion and the Risk of Dementia: A Population-Based Study
Wolters, F. J., Zonneveld, H. I., Hofman, A., van der Lugt, A., Koudstaal, P. J., Vernooij, M. W., & Ikram, M. A. (2017) · Circulation · doi:10.1161/circulationaha.117.027448 · Cited by 520
Pericyte degeneration leads to neurovascular uncoupling and limits oxygen supply to brain
Kisler, K., Nelson, A. R., Rege, S. V., Ramanathan, A., Wang, Y., Ahuja, A., Lazic, D., Tsai, P. S., Zhao, Z., Zhou, Y., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4489 · Cited by 497
Chen, Y., & Gorski, D. H. (2008) · Blood · doi:10.1182/blood-2007-07-104133 · Cited by 458
Grammas, P. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-26 · Cited by 432
Age-associated Physiological and Pathological Changes at the Blood-Brain Barrier: A Review
Erdő, F., Denes, L., & de Lange, E. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16679420 · Cited by 426
“Protein expression of the glucose transporter GLUT1 is reduced in brain capillaries in Alzheimer’s disease, without changes in GLUT1 mRNA structure(119) or levels of GLUT1 mRNA transcripts.(120) Furthermore, a reduction in CNS energy metabolites has been seen in several Positron Emission Tomography (PET) scanning stud…”
BackgroundCentral role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410
Self-citationMartins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Role of Blood-Brain Barrier in Alzheimer’s Disease
Cai, Z., Qiao, P.-F., Wan, C.-Q., Cai, M., Zhou, N.-K., & Li, Q. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-180098 · Cited by 370
Boekhoorn, K., Joels, M., & Lucassen, P. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.04.017 · Cited by 325
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
“MEOX2 homeobox gene controls LRP1 expression at the BBB, and might link to neurovascular dysfunction in AD (85), while another group reported that haploinsufficiency of the MEOX2 gene did not affect plaque deposition in APP/PS1 mice (86).”
BackgroundKalaria, R. N. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00352.x · Cited by 290
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
The Pericyte: A Forgotten Cell Type with Important Implications for Alzheimer's Disease?
Winkler, E. A., Sagare, A. P., & Zlokovic, B. V. (2014) · Brain Pathology · doi:10.1111/bpa.12152 · Cited by 278
Self-citationGovindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050651 · Cited by 275
Kelleher, R. J., & Soiza, R. L. (2013) · Europe PMC (PubMed Central) · Cited by 271
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Di Marco, L. Y., Venneri, A., Farkas, E., Evans, P. C., Marzo, A., & Frangi, A. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.08.014 · Cited by 262
SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cells
Bell, R. D., Deane, R., Chow, N., Long, X., Sagare, A., Singh, I., Streb, J. W., Guo, H., Rubio, A., Van Nostrand, W., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1819 · Cited by 261
Self-citationZlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., & Winkler, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07002.x · Cited by 261
Self-citationAltered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease
Meyer, E. P., Ulmann-Schuler, A., Staufenbiel, M., & Krucker, T. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709788105 · Cited by 260
Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance
Singh, I., Sagare, A. P., Coma, M., Perlmutter, D., Gelein, R., Bell, R. D., Deane, R. J., Zhong, E., Parisi, M., Ciszewski, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302212110 · Cited by 254
Self-citationNeurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
Self-citationThe blood–brain barrier in neurodegenerative disease: a rhetorical perspective
Carvey, P. M., Hendey, B., & Monahan, A. J. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06319.x · Cited by 251
McAllister, T. W., Ford, J. C., Ji, S., Beckwith, J. G., Flashman, L. A., Paulsen, K., & Greenwald, R. M. (2012) · Annals of Biomedical Engineering · doi:10.1007/s10439-011-0402-6 · Cited by 251
Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer’s patients
Mertens, J., Herdy, J. R., Traxler, L., Schafer, S. T., Schlachetzki, J. C. M., Böhnke, L., Reid, D. A., Lee, H., Zangwill, D., Fernandes, D. P., et al. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.04.004 · Cited by 240
Aging of the brain, entropy, and Alzheimer disease
Drachman, D. A. (2006) · Neurology · doi:10.1212/01.wnl.0000240127.89601.83 · Cited by 235
Single-cell label-free photoacoustic flowoxigraphy in vivo
Wang, L., Maslov, K., & Wang, L. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215578110 · Cited by 218
Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608251104 · Cited by 209
Self-citationMiners, J. S., Schulz, I., & Love, S. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17690761 · Cited by 208
“Deletion of the Meox2 gene in mice resulted in a perfusion deficit that was associated with increased Ab level (due to impeded LRP-1mediated clearance).(31) Mice deficient in platelet-derived growth factor receptor-b (Pdgfrbþ/ ), a specific marker of pericytes,(32) showed age-related loss of pericytes, associated with…”
Lin, A.-L., Zheng, W., Halloran, J. J., Burbank, R. R., Hussong, S. A., Hart, M. J., Javors, M., Shih, Y.-Y. I., Muir, E., Fonseca, R. S., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.82 · Cited by 208
Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205
Self-citationCerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases
Grammas, P., Martinez, J., & Miller, B. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411001918 · Cited by 202
Li, Q., Ford, M. C., Lavik, E. B., & Madri, J. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21087 · Cited by 202
The capillary dysfunction hypothesis of Alzheimer's disease
Østergaard, L., Aamand, R., Gutiérrez-Jiménez, E., Ho, Y.-C. L., Blicher, J. U., Madsen, S. M., Nagenthiraja, K., Dalby, R. B., Drasbek, K. R., Møller, A., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.09.011 · Cited by 199
Foster, P. P., Rosenblatt, K. P., & Kuljiš, R. O. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00028 · Cited by 198
Blood-brain barrier and cerebral small vessel disease
Wardlaw, J. M. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.042 · Cited by 198
Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study
Starr, J. M., Farrall, A. J., Armitage, P., McGurn, B., & Wardlaw, J. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.04.003 · Cited by 189
Dysfunction of the blood–brain barrier in Alzheimer's disease: Evidence from human studies
Kurz, C., Walker, L., Rauchmann, B., & Perneczky, R. (2022) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12782 · Cited by 183
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses
(2024) · aging and disease · doi:10.14336/ad.2023.0608 · Cited by 183
“However, it is unclear whether reduced MEOX2 expression represents a genetic risk factor for AD or is caused by the neurodegeneration processes [255, 256].”
BackgroundDeane, R., Sagare, A., & Zlokovic, B. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784705487 · Cited by 183
Self-citationHawkes, C. A., Sullivan, P. M., Hands, S., Weller, R. O., Nicoll, J. A. R., & Carare, R. O. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041636 · Cited by 180
Lin, W.-T., Chen, R.-C., Lu, W.-W., Liu, S.-H., & Yang, F.-Y. (2015) · Scientific Reports · doi:10.1038/srep09671 · Cited by 172
Mechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
Herzig, M. C., Nostrand, W. E., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 169
TAKANO, T., HAN, X., DEANE, R., ZLOKOVIC, B., & NEDERGAARD, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.004 · Cited by 168
Self-citationCell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia
Engelhardt, S., Patkar, S., & Ogunshola, O. O. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12489 · Cited by 168
Neurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
Sagare, A. P., Bell, R. D., & Zloković, B. V. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129037 · Cited by 166
Self-citationThe Neurovascular Unit Dysfunction in Alzheimer’s Disease
Soto-Rojas, L. O., Pacheco-Herrero, M., Martínez-Gómez, P. A., Campa-Córdoba, B. B., Apátiga-Pérez, R., Villegas-Rojas, M. M., Harrington, C. R., de la Cruz, F., Garcés-Ramírez, L., & Luna-Muñoz, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042022 · Cited by 136
Amatschek, S., Kriehuber, E., Bauer, W., Reininger, B., Meraner, P., Wolpl, A., Schweifer, N., Haslinger, C., Stingl, G., & Maurer, D. (2007) · Blood · doi:10.1182/blood-2006-10-053280 · Cited by 136
Toward more predictive genetic mouse models of Alzheimer’s disease
Onos, K. D., Sukoff Rizzo, S. J., Howell, G. R., & Sasner, M. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2015.12.003 · Cited by 156
Scuteri, A., Nilsson, P. M., Tzourio, C., Redon, J., & Laurent, S. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347cc17 · Cited by 151
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zlokovic, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 151
Sagare, A. P., Deane, R., & Zlokovic, B. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.008 · Cited by 143
Self-citationShedding of soluble platelet-derived growth factor receptor-β from human brain pericytes
Sagare, A. P., Sweeney, M. D., Makshanoff, J., & Zlokovic, B. V. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.09.025 · Cited by 142
Self-citationLRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier
Pflanzner, T., Janko, M. C., André-Dohmen, B., Reuss, S., Weggen, S., Roebroek, A. J. M., Kuhlmann, C. R. W., & Pietrzik, C. U. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.025 · Cited by 141
The Role of Pericytes in Neurovascular Unit Remodeling in Brain Disorders
ElAli, A., Thériault, P., & Rivest, S. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15046453 · Cited by 139
Thal, D. R., Capetillo-Zarate, E., Larionov, S., Staufenbiel, M., Zurbruegg, S., & Beckmann, N. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.017 · Cited by 138
Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives
Fisher, R. A., Miners, J. S., & Love, S. (2022) · Brain Pathology · doi:10.1111/bpa.13061 · Cited by 131
Blasko, I., Jellinger, K. A., Kemmler, G., Krampla, W. W., Jungwirth, S., Wichart, I., Tragl, K. H., & Fischer, P. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.09.002 · Cited by 130
Protection after stroke: cellular effectors of neurovascular unit integrity
Posada-Duque, R. A., Barreto, G. E., & Cardona-Gomez, G. P. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00231 · Cited by 123
Pienaar, I. S., Lee, C. H., Elson, J. L., McGuinness, L., Gentleman, S. M., Kalaria, R. N., & Dexter, D. T. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.006 · Cited by 125
“, 1997) or the levels of GLUT-1 mRNA transcripts (Wu et al., 2005).”
InfluentialLang, I., Schweizer, A., Hiden, U., Ghaffari‐Tabrizi‐Wizsy, N., Hagendorfer, G., Bilban, M., Pabst, M. A., Korgun, E. T., Dohr, G., & Desoyé, G. (2008) · Differentiation · doi:10.1111/j.1432-0436.2008.00302.x · Cited by 125
Cerebrospinal Fluid Biomarkers of Neurovascular Dysfunction in Mild Dementia and Alzheimer'S Disease
Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.76 · Cited by 122
Self-citationMeox2/Tcf15 Heterodimers Program the Heart Capillary Endothelium for Cardiac Fatty Acid Uptake
Coppiello, G., Collantes, M., Sirerol-Piquer, M. S., Vandenwijngaert, S., Schoors, S., Swinnen, M., Vandersmissen, I., Herijgers, P., Topal, B., van Loon, J., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013721 · Cited by 109
The blood brain barrier in Alzheimer’s disease
Chakraborty, A., de Wit, N. M., van der Flier, W. M., & de Vries, H. E. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2016.11.008 · Cited by 118
Hawkins, B. T., Sykes, D. B., & Miller, D. S. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5103-09.2010 · Cited by 113
DNA methylation signature of human hippocampus in Alzheimer’s disease is linked to neurogenesis
Altuna, M., Urdánoz‐Casado, A., de Gordoa, J. S., Zelaya, M. V., Labarga, A., Lepesant, J. M. J., Roldán, M., Blanco‐Luquin, I., Perdones-Montero, Á., Larumbe, R., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0672-7 · Cited by 113
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer’s disease
Canobbio, I., Abubaker, A. A., Visconte, C., Torti, M., & Pula, G. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00065 · Cited by 112
Pathophysiology of the Blood–Brain Barrier: Animal Models and Methods
Hawkins, B. T., & Egleton, R. D. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)80007-x · Cited by 109
Liu, L., Wan, W., Xia, S., Kalionis, B., & Li, Y. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.05.004 · Cited by 107
Role of neuroinflammation in hypertension-induced brain amyloid pathology
Carnevale, D., Mascio, G., Ajmone‐Cat, M. A., D’Andrea, I., Cifelli, G., Madonna, M., Cocozza, G., Frati, A., Carullo, P., Carnevale, L., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.08.013 · Cited by 106
Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease
Yin, X., Wright, J., Wall, T., & Grammas, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090406 · Cited by 104
Yang, F., Lu, W.-W., Lin, W., Chang, C., & Huang, S.-L. (2014) · Brain stimulation · doi:10.1016/j.brs.2014.11.017 · Cited by 102
Patel, N. S., Mathura, V. S., Bachmeier, C., Beaulieu‐Abdelahad, D., Laporte, V., Weeks, O., Mullan, M., & Paris, D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06426.x · Cited by 99
From Neurodevelopmental to Neurodegenerative Disorders: The Vascular Continuum
Ouellette, J., & Lacoste, B. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.749026 · Cited by 98
Blood–Brain Barrier and Neurodegenerative Diseases—Modeling with iPSC-Derived Brain Cells
Wu, Y.-C., Sonninen, T.-M., Peltonen, S., Koistinaho, J., & Lehtonen, Š. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147710 · Cited by 89
Alzheimer's Disease: Cerebrovascular Dysfunction, Oxidative stress, and Advanced Clinical Therapies
Marlatt, M. W., Lucassen, P. J., Perry, G. L., Smith, M. A., & Zhu, X. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15206 · Cited by 97
MicroRNA-130a Mediates Proliferation of Vascular Smooth Muscle Cells in Hypertension
Wu, W., Hu, C., Chen, X.-P., Zhang, W., Li, X. W., Xiong, X.-M., & Li, Y.-J. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.116 · Cited by 97
Cerebrovascular disorders: molecular insights and therapeutic opportunities
Storkebaum, E., Quaegebeur, A., Vikkula, M., & Carmeliet, P. (2011) · Nature Neuroscience · doi:10.1038/nn.2947 · Cited by 96
Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler
Claassen, J. A. H. R., Diaz-Arrastia, R., Martin-Cook, K., Levine, B. D., & Zhang, R. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1079 · Cited by 95
The Abluminal Endothelial Membrane in Neurovascular Remodeling in Health and Disease
Hermann, D. M., & ElAli, A. (2012) · Science Signaling · doi:10.1126/scisignal.2002886 · Cited by 93
The relationship between amyloid-beta and brain capillary endothelial cells in Alzheimer’s disease
Su, Q., Guo, J.-H., Zhang, Y.-L., Wang, J., & Zhang, Z.-N. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335829 · Cited by 91
“The low level MEOX2 expression in brain endothelial cells promotes proteasomal degradation of LRP1 and downregulates LRP1 expression (Wu et al., 2005).”
BackgroundOscillations in cerebral blood flow and cortical oxygenation in Alzheimer's disease
van Beek, A. H. E. A., Lagró, J., Olde-Rikkert, M. G. M., Zhang, R., & Claassen, J. A. H. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.016 · Cited by 90
Metadata
- Authors
- Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., Liu, D., Li, F., Armstrong, D., Gasiewicz, T., Zidovetzki, R., Song, X., Hofman, F., & Zlokovic, B. V.
- Affiliations
- University of Rochester Medicine (US)
- Socratech (United States) (US)
- University of California, Riverside (US)
- University of Southern California (US)
- ORCID
- Venue
- Nature Medicine
- Published
- 2005-08-14
- Volume
- 11
- Issue
- 9
- Pages
- 959-965
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2059559668
- Cited by
- 280
- References
- 50
- Citations by year
- 2026: 6 · 2025: 3 · 2024: 5 · 2023: 13 · 2022: 18 · 2021: 11 · 2020: 11 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 9 · 2015: 22 · 2014: 14 · 2013: 17 · 2012: 13
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r43ag024002-01)
- Medical Center, University of Rochester
- National Institute on Aging (R37AG023084, R43 AG23993, R43AG023993, R43 AG24002)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- MEOX2, homeobox genes, Alzheimer's disease, neurovascular dysfunction, brain endothelial cells, angiogenesis, apoptosis, amyloid-beta clearance, LRP1, blood-brain barrier, cerebral blood flow, gene silencing
- MeSH terms
- Alzheimer Disease, Animals, Brain, Cells, Cultured, Frontal Lobe, Gene Expression Regulation, Genes, Homeobox, Humans, Mice, Transgenic, Apoptosis, Mice, Knockout, Homeodomain Proteins, Neovascularization, Physiologic, Gene Expression Profiling, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.